Live feed
Filing
SC 13D
SC 13D0001193125-16-725794·Allergan plc
Schedule 13D ownership disclosure
Tobira Therapeutics Inc
Security class unavailable · CUSIP: 88883P101
Event date: 2016-09-19
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 36.3000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-16-725794
- Form type
- SC 13D
- Filer
- Allergan plc
- CIK
- CIK 1578845
- Filed
- Sep 29, 2016
- Reporting period
- Sep 19, 2016
- Description
- Schedule 13D beneficial ownership